Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JCOG1016 SANTA study in anaplastic glioma
jRCTs031180215Phase 3Active, not recruiting
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Jul 2014
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in anaplastic glioma comparing Temozolomide + radiotherapy with Nimustine + radiotherapy (2 arms). Primary endpoint: Overall survival. Started Jul 2014; status: active, not recruiting.
02
Drugs
temozolomidenimustine
03
Conditions
anaplastic glioma
Beyond the preview
Go deeper on jRCTs031180215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180215.